AIM-listed Haydale (HAYD), fresh from its bailout keep-the-lights-on placing and open offer at 2p in which it raised £5.5 million (gross) last month, has announced its full year results, to June 30, this morning. The numbers are truly grim.

AIM-listed graphene outfit Haydale (HAYD) triumphantly announced the completion of its latest bailout keep-the-lights-on fundraising this morning. With £5 million in the bag – and an open offer to existing shareholders to raise a bit more at 2p – the company was pleased to announce that this latest fundraise, worth around half of the current market capitalisation, would be used predominantly to fund the general working capital needs of the business. Tosh! It will be used to fund the seemingly unending ongoing losses! What is it about AIM-listed graphene businesses?

By my back-of-an-envelope, AIM-listed Haydale (HAYD) is once again almost all out of cash – I reckoned HERE that the coffers could be bare before the end of September. Having burned through £430,000 in June alone, the company had £1.19 million at the close of June. So what will the company do?

When AIM-listed Haydale (HAYD) released a trading update AHEAD of its full year at the end of June, seemingly indicating that all was well, I wondered if that was really the case. Well, this morning we know the answer to that, after a full-year trading update. All most certainly is not well – and the shares are already down by 5.5%.

AIM-listed Haydale (HAYD) has offered up a trading update ahead of its full year to June 2022. Apparently all is well, with revenues ahead of expectations but is that really the case?

AIM-listed Haydale (HAYD) issued an RNS Reach this morning to announce that it is celebrating a double award win, with the Group picking up an award at the prestigious 2022 British Engineering Excellence Awards ('BEEAs') and named as a winner of the Kidney Research UK MedTech Competition respectively. But…..

AIM-listed graphene play Haydale (HAYD) announced its interim results to December 2021 this morning and despite the advertised £3.84 million of cash, yet another placing is surely inevitable. Revenues fell from £1.28 million to £1.19 million, pre-tax losses increased from £1.93 million to £2.46 million year on year – what’s not to like? But the real problem is the balance sheet.

Last week saw yet another RNS Reach announcement from AIM-listed Graphene play Haydale (HAYD). Reach announcements are used for non-regulatory news, ie non-financially significant announcements and advertising, so a deluge of them is a Red Flag for me, indicating it is bucket-shop placing ahoy.

A rise in the shares of AIM-listed Applied Graphene (AGM) caught my eye today. Like Haydale (HAYD) and Versarien (VRS) – apparently – it is a graphene play on the world’s most successful growth market. So how is the growth here? Er…..

On Monday AIM listed Haydale (HAYD) announced the appointment of new Nomad/Broker FinnCap. Yesterday there was a first RNS Reach spoof and today there is another. With cash surely inadequate to get through the auditor’s Going Concern test later this year, I ask again: when’s the placing.

AIM-listed graphene play Haydale (HAYD) is up to its old tricks again with the release of an RNS Reach telling us that iCraft is using Haydale’s graphene product in a graphene-coated fabric. Yesterday we were told of the appointment of a new Nomad/Broker, today we get an RNS Reach. When’s the placing fellas?

AIM-listed Graphene play Haydale (HAYD) has appointed FinnCap as Nomad and Broker. So is it fundraising ahoy?

AIM-listed graphene products company Haydale (HAYD) has released its full year results to June 30 2021. Amongst the highlights we are told of a “robust trading performance” and the “Summary of Results” shows that cash outflow from operations was down by 52% whilst cash at year end was up by 100% at £1.64 million. So all is well, right? Think again…..

In my last piece on AIM-listed Haydale (HAYD) at the beginning of this month I discussed a ramparoonie RNS revealing an undeclared related party and a tin-pot organisation casting a very different light on matters as presented by the company. What was the point? Of course – it was a pre-placing ramp and this morning it was time for Ouzo on cornflakes as Haydale revealed a fundraise at just 6p per share. That, against a peak last week of 7.55p.

AIM-listed Haydale (HAYD) has announced a Memorandum of Understanding with a company called Viritech Limited via and RNS Reach this morning. Of course, and RNS Reach is not a full RNS and should be treated more as marketing material, certainly with no implied financial impact. A trip to Companies House shows us why……

Tom Winnifrith has already exposed the cancer threat, discussed HERE in a 2018 scientific study, posed by wearing graphene enhanced face masks with regard to AIM-listed Versarien (VRS). But it seems that Versarien is not the only company in the firing line, for AIM-listed Haydale (HAYD) is also on the hook.

AIM-listed Haydale Graphene (HAYD) has offered up its interims to December 2020 today and whilst the company flags increased sales of functionalised inks graphene and points to falling admin costs and operating losses, these are on an adjusted basis. The unadjusted truth is that sales of £1.277 million were down from £1.347 million the previous year and the company lost £2 million in total comprehensive loss (although this is marked as being for the year – not that there was an cut’n’paste laziness!)

I wondered about the complete non-mention of those clever face masks that AIM-listed Haydale Graphene (HAYD) is supposed to be producing shed-loads of graphene for with regard to the trading statement last week. The more I think about it, the more surprising it is.

AIM-listed Haydale Graphene (HAYD) offered up a statement on Thursday telling of a sales representative agreement and a trading update. The former offered up visions of Tom Winnifrith’s (lack of) wooing Britain’s favourite chanteuse but the latter seems to me have been more a case of the dog that didn’t bark. What was the first elephant in the room?

AIM-listed Haydale Graphene (HAYD) has announced the great achievement of its Functionalised Graphene Antibacterial Masks project going into production with partner IRPC Public Company. Put up the bunting, get the champagne ordered……or perhaps not, for surely it has missed the boat.

AIM-listed graphene outfit Haydale Graphene Industries (HAYD) was “pleased to announce” its interims to June this morning – I’m not sure why, for a £14 million market capitalisation company to offer up a pre-tax loss of £4.4 million in just six months is surely nothing to be pleased about.

I have warned and warned and warned that AIM-listed Haydale (HAYD) needed more money and having jumped on the Covid-Bandwagon at the beginning of July and seen its shares slide from 8.45p on 20^th August to last night’s close at just 5.1p, this morning the company announced a bookbuild at just 3.5p to raise £3 million. The only question is whether it should be Ouzo on my Cornflakes or my Rice Krispies.

I have warned and warned that AIM-listed Haydale (HAYD) would need more money and as ramptastic RNS after ramptastic RNS has been issued by the company as it has joined the Covid-bandwagon, despite a calamitous profit warning in April the shares have been rising and rising. Today, they stopped going up: is there a placing on the way? Do we need a statement from the company?

Another day, another AIM dog jumps on the Covid bandwagon – Haydale (HAYD) has announced a new collaboration agreement between its Thai operation, Haydale Technologies (Thailand) Co. Ltd and IRPC Public Company Limited to develop Organic conducting-based printing smart fabric (Contract No. AL.0748/2563), by using Haydale's functionalised technology. Market madness is still apparent: the shares roofed it to 3.225p, up an impressive 57% on the news. So what’s the problem?

After last week’s jam-tomorrow ramparoonie, today AIM-listed Haydale (HAYD) offered up a calamitous profit warning. Oh dear, oh dear, oh dear…..

AIM-listed Haydale (HAYD) has announced an initial four-year distributer agreement with Dalian Yibang Technology Co Ltd (DLYB) offering exclusive distributer rights to market Haydale’s electrically conductive graphene-enhanced masterbatch in China and Taiwan. All well and good – and it does indeed appear to be good news – but for all the jam tomorrow, what about cash today?

Having made a total shambles of its half-year trading statement to the end of December, contradicting itself the very next day, AIM-listed Haydale (HAYD) has offered up dire interim results. The company will need more cash – and given the fiasco last time, that spells bad news for shareholders.

Having sent a missive to AIM Regulation yesterday concerning AIM-listed Haydale (HAYD) and its Trading Update which appeared to admit to contravention of AIM Rule 11, the company issued a clarification RNS which appeared to me to completely contradict the original one, and both were signed off by Nomad Arden Partners under the watchful eye of the fine upstanding Mr Paul Shackleton, of China-fraud Naibu (NBU) and Daniel Stewart infamy. Call me old-fashioned, but the two statements appear to me to be impossibly contradictory – and that brings me to AIM Rule 10. Thus I have written again to AIM Regulation.

Following my letter to AIM Regulation this morning, AIM-listed Haydale Graphene (HAYD) has attempted to quell the reaction to yesterday’s trading update, which appears to show that the company was allowed by its Nomad to breach AIM Rules by offering a clarification. But it is attempting to clarify the unclarifiable.

Yesterday I showed that AIM-listed Haydale (HAYD) appeared to have been breaking AIM Rule 11 upon the disclosure that a new line in the States had seen commissioning delayed until November, despite the company appearing to have told the market that it had been in commercial production since last June in an RNS dated 15 October – when one now presumes that commissioning was known by the company to be delayed.

AIM-listed Haydale Graphene Industries (HAYD) offered up a pretty grim trading statement this morning showing that sales at its US unit were materially below those of H1 2019 during H1 2020. Oopsie. Meanwhile UK operations suffered from longer than anticipated lead times and sales fell short of directors’ expectations. Double oopsie. And the company has shuttered its Taiwan operation which will lead to a revenue shortfall in H2 of around £0.4 million. Triple oopsie – and now we are told that full year sales will come in below market expectations (whatever they are). What’s not to like?!

My slam-dunk sells for 2019 came home ahead, but only 8% down on their starting prices. Of the five, Haydale (HAYD) was an early success as the rescue bailout I had long predicted it needed finally arrived…..and smashed the shares from 31.5p at the start of the year to a couple of pence.

We are almost at year-end and my collection of sells from the start of the year looks fairly set for its second deletion. But how are the others doing, given that at the last count my notional portfolio of sells was down 13% (ie to sell had been the correct call)?...

I still reckon AIM-listed graphene outfit Haydale (HAYD) needs to get a placing away pronto but today comes the bombshell that the CFO – who has only been in the job for 10 months – is stepping down. Do I detect a case of rats and sinking ships?

Having suggested that AIM-listed graphene outfit Haydale (HAYD) was once again a slam-dunk sell, partly in view of there being no sign of its results, the company finally delivered them last Tuesday. But I had also pointed to the preponderance of RNS Reach announcements, one of which accompanied the FY results. And this morning there was another.

My most recent call to sell fashionable graphene promote Haydale (HAYD) was on its full-year trading update back in July, an update which told readers very little: I said sell at 1.775p and the shares are now just 1.125p. More ouzo for me!

My slam-dunk sells for 2019 are looking better and better (if you are a bear). In my last piece (in September) the average had got almost back to flat but the interim results season took its toll on one of the portfolio and I am now in profit.

I’ve already waved bye-bye to Haydale (HAYD) when it collapsed earlier this year on a massively discounted rescue refinancing – as long predicted by yours truly – saw me call it a win. Now it seems that Walcom (WALG) is finally heading for the corporate knackers’ yard next month, unless some miracle happens and the shares are down to just 0.25p. That will be two out of five if/when (with emphasis on the when) it happens. All hail the ShareProphets AIM-China Filthy Forty, from where it made this year’s sell list.

It is just over a month since my last update, when my portfolio of five sells was actually showing a profit of 19.5% to anyone who bought as opposed to sold. Egg-on-face time! So how are things looking now – is it still sackcloth and ashes for me?

I’ve been a bear of AIM-listed Haydale (HAYD) all the way down from 120p, and saying sell at 78p, to today’s miserable 1.775p but this morning’s trading statement gives me no reason to change my stance. I may have closed out in my five slam-dunk sells for this year but even then I warned that  I would still be inclined to sell and I certainly wouldn’t buy here. Well, we’ve had a trading statement this morning – more remarkable for what it does not say rather than what it does, and that is never a good sign.

With the Neil Woodford debacle I’ve taken my eye off the ball here – many apologies. So here is an update on my five AIM sells for 2019, the first since the end of March.

Last month one of the five had its denouement as AIM-listed Haydale (HAYD) had an emergency bailout  - as long predicted by me -  at only 2p. That left just four. My suspicion was that AIM-listed member of the Filthy Forty, Walcom (WALG) would be next with its head under the guillotine and the news there was only marginally better as death has been postponed to June.

Oh dear – things are going from bad to worse at AIM-listed Haydale. The bailout refinancing had to be repriced down to just 2p and the open offer raised less than half the amount wanted. And now the shares have fallen below the bailout price – which was set at 2p, the nominal (or par) value of the shares which make raising any more cash a tad difficult.

They say that a week is a long time in politics (attributed to Harold Wilson), and so it seems with the equity markets. A week ago my portfolio of five shares to sell was actually up by 4.6%. Now, all of a sudden we are at minus 8.6%.

I cover the matter in the tiitle at the end of this podcast and also remind you that tomorrow is my first long training walk for the 33 mile Woodlarks trek in the summer where we now have EIGHT rogue bloggers signed up and where I ask each bearcast listener to think of me tomorrow and donate a tenner HERE. In the podcast I discuss my unhappiness over City behaviour at Reach4Entertainment (R4E), Yourgene (YGEN) and ref Chris Oil. I stress that I own shares in Yourgene and Reach and both are cheap notwithstanding my unhappiness. I look at Haydale (HAYD), Flybe (FLYB) and Chesterfield (CHF)

I sincerely hope that no ShareProphets readers were left holding this particular baby we warned you often anough.

Today's podcast focusses in on the sheer stupidity of some private investors and covers Flybe (FLYB), Haydale (HAYD), Telit (TCM) and finally the disgraceful tale of crony capitalism that is Davictus (DVT).

Well here we are: I’ve  been saying for months that AIM-listed Haydale (HAYD) had to raise cash in a material way, all the way down from 78p last June and now we have word of a placing at just 5p which Steve Moore published yesterday. Amazingly, even after the company more-or-less confirmed our story (or failed to deny) the shares still sit at 12.25p, having been as low as 9.75p. Some people simply won’t be told. But Proactive should be shame-faced.

It is four weeks since my last update, so it is time to take another look at my sells for 2019. The five have, as a whole, had a better month but I cannot help but think that for three of them the precipice approaches...

Back on 27 November 2018, AIM-listed Haydale (HAYD) announced (via RNS Reach, mind you) a collaboration with NEX-listed Wheelsure (WHLP) was being joined by Manchester University’s Graphene Engineering Innovation Centre (GEIC) in a project to develop an intelligent new product pairing Haydale's functionalised graphene sensor technology with Wheelsure's failsafe locking solution. Of course, Haydale needed cash then (as it does now). But then so did Wheelsure (see HERE). As such it all looked like a ramp.

I thought I’d update on my 5 sells for 2019 as after just a couple of weeks a few cracks are beginning to show already. The five, Telit (TCM), Haydale (HAYD), Yu Group (YU.), Walcom (WALG) of the ShareProphets AIM-China Filthy Forty and First Derivatives (FDP) are not necessarily shorts – some, such as Walcom, couldn’t be shorted anyway. But they are sells.

I see that AIM-listed Haydale (HAYD) has released yet another RNS Reach to tell of an eighteen month supply agreement. The shares have jumped once again, by 12%, But, of course, it is an RNS Reach and thus should be viewed as a marketing, rather than anything significant such as mega-earnings.

AIM-listed Haydale (HAYD) is still seeing its management selling shares and another institution seems to be bailing out. Of course, we know that Haydale needs a placing and it is only a matter of time before the £3.2 million black hole in the balance sheet as predicted by paid-for researcher Hardman (so I’ll bet it is more) has to be addressed.

It was announced on Friday that the former CEO and now former board member of AIM-listed Haydale (HAYD) has been selling shares. Back in December it was his two colleagues at Haydale Ceramic Technologies dumping shares (over £110,000 worth). In September, former boss Ray Gibbs sold about 38,000 bits of confetti and now he’s sold a further 80,000 shares. That’s a fair bit of selling by insiders!

I have been calling AIM-listed Haydale lower from 78p last June, in the wake of a nasty profit warning. Since then we have had two more, and even the company’s paid-for ramper research company Hardman admits the company needs more cash but Haydale sat on its hands instead of biting the bullet until raising a pitiful £250,00 in a placing at 20p shortly before Christmas and kicked the can down the road with a further £750,000 loan (at 11% interest).

And so, at long last, AIM-listed graphene play Haydale (HAYD) has raised some money. With the shares closing at 25.5p last night, it raised just £250,000 in a placing at 20p (a 21.5% discount) and £750,000 by way of a loan from the Development Bank of Wales at 11%. Oh, and we have a new finance director (did he jump or was he pushed), the former CEO (who stepped down on the profit warning back in June) is off (did he jump or was he pushed too?) and so is a NED. 

We all know that AIM-listed Haydale needs to raise money, and we have had all forms of pumping to support it in the form of RNS Reaches and paid-for broker notes. Now we see reannounced old news from NEX-listed Wheelsure (WHLP) regarding the joint venture with Haydale and the University of Manchester which Haydale announced on 27 November (and Wheelsure announced on the 26^th)! Even Haydale didn’t even bother with an RNS Reach, although an announcement went out via Alliance News: never miss the opportunity to re-inform! But this does beg one or two questions.

AIM-listed purveyor of all things graphene, Haydale (HAYD) has been on an RNS Reach-fest, the latest of which came this morning. Of course, RNS Reach announcement are by definition immaterial and are best viewed as free advertising. But the market has bought into the ramp and the shares are markedly up on the 12p low point they reached when it emerged – along with proft warning No. 3 in six months – that Haydale had been unable to raise loan finance it had planned to. The stock is now up at 36.5p – still a long way down from the 78p at which I wrote about the company last June.

In today's podcast I look at Tomco (TOM), Watchstone (WTG), the bastard son of Quenron, Condor Gold (CNR), dire numbers from WH Ireland (WHI) and the read across to the FinnCrap IPO, Amedeo Resources (AMED), the Sith Lord Zak Mir and Optibiotix (OPTI) and at Haydale (HAYD)

AIM-listed and almost out of cash Haydale (HAYD) has issued yet another RNS Reach, this time to tell us that it has signed an exclusive deal with TKS Siampress Management for an anti-counterfeiting product. Whoopie doo – but there are, predictably, no numbers offered. And an RNS Reach is for news which is, effectively, not material.

As covered here on ShareProphets many times, AIM-listed Haydale (HAYD) is in deep trouble as finally admitted last Friday. I’ve been saying sell all the way down from 78p in June of this year and the shares plunged to just 13.5p on Friday – after the company warned it was short of cash and offered, effectively, yet another profit warning (the third in three months). Last night the shares were 12.25p and Hardman, which ramped the shares after hours in September only to see the shares fall in response the next day, has had another go. It is laughable.

Having warned repeatedly on this website that AIM-listed Haydale (HAYD) was in trouble and that the shares were a sell all the way down from 78p only in June of this year (and steered a wide berth at 120p in October last year), yesterday the shares crashed to just 14p last seen – a fall of 40% on the day. This follows a Financing Update which is a calamity in every way.

AIM-listed Haydale (HAYD) has announced that it has got a grant of £120,000 from a package worth £249,600 and the shares have raced ahead by 21% to 32p. Of course, the RNS announcing the funding was an RNS reach and therefore does not affect the dire financial position of the company, which I fear may be doomed. Shareholders would be well advised to look skywards in gratitude and view the rise as a welcome opportunity to exit.

I can’t help but notice that shares in AIM-listed Haydale have been on the slide once more. Today they are off by another 13.2% - I wonder if the company wants to issue a statement as to the reason why? Na….thought not. Well, just to help out Haydale (‘cos we are such nice guys)…..

Yesterday afternoon while the city was tuning in to the Ryder Cup, AIM-listed Haydale (HAYD) released an RNS announcing the sale of 38,233 shares (about 7.7% of his holding) by director Ray Gibbs – the CEO who announced his intention to step down in June on the back of a profit warning – on 26^th September, the day before Hardman issued its after-hours ramptastic buy note.

Yesterday at 5.20pm – no-one-is-watching o’clock – paid-for research house put out some piffle about AIM-listed Haydale (HAYD). The shares are attractively valued compared with their peer group, on P/NAV and EV/sales, and also on a DCF basis don’cha know. Well, maybe – apart from the fact it is loss-making, going to run out of cash and the last placing was at a 32% discount! If the company thought that would get a lift in the share price, I’ve got bad news….

Shares in AIM-listed graphene play Haydale (HAYD) are off again to 44p (mid, last seen) following full year results to June this morning. Following a profit warning in June, when I said this was a bargepole stock at 78p and suggested that we were in for a £6 million loss before tax, cash would be down to around £5 million at year-end and another big cash-call was on the way, let’s see how my Mystic Meg powers are holding up……

AIM-listed graphene play Haydale (HAYD) announced a Contract Updates % Notice of Results RNS this morning. Don’t be fooled: there’s a placing coming and the updates are a tad over-dressed to help.

Shares in AIM-listed Haydale have been a one-way bet to financial destruction ever since it conducted a placing at 120p (a discount to the then share price of some 32%). In the wake of a trading warning and the stepping aside of its CEO, the stock has now crashed to just 50.5p – the stock gave up a further 14% on Friday alone. The problem is that it needs to get another bailout placing away.

AIM-listed Haydale (HAYD) has issued another RNS Reach announcement to add to the one released on June 19^th. But we all know (don’t we?) that RNS Reach announcements are effectively marketing ploys, not hard news of cashflow. And we also know that Haydale has to get a placing away in order to get its accounts signed off as a going concern.

AIM-listed Haydale offered a terrible trading update the week before last, announced the CEO was moving aside and we know it needs to raise cash. In that context, the ramptastic pre-placing RNS Reach of Tuesday and a sub-£9,000 director’s-wife’s buy announced on Wednesday would appear to need taking with a large pinch of salt. Last night, at 4.20pm, however, we learnt that Legal & General had been selling.

Yesterday afternoon, AIM-listed Haydale (HAYD) announced a buy by the wife of one of the NEDs. That should be good news, but I see it as bad news - especially as we all know the company needs to get a placing away and has just announced a crap trading update.

AIM-listed Haydale (HAYD) has offered the market an RNS this morning describing “Strong Commercial Progress”. Bearing in mind the profit warning of last week, and the inevitability of another bailout placing one wonders if this marks the appearance of pastures new in the distance, or whether it is just a pre-placing ramp.

The reference to scumbags John Belliss and Gavin Burnell is explained in full in this podcast which covers CyanConnode (CYAN), Audioboom (BOOM), Magnolia Petroleum (MAGP), Revolution Bars (RBG), Peter Schiff and the economy, AIQ (AIQ), Tern (TERN) and Haydale (HAYD).  Both Brokerman Dan and I are now training with blisters. This weekend I move up to a 14 mile walk ahead of our 32 mile July 28 stroll for Woodarks. Thanks to all who have sponsored us. swe have now raised more than £8,000 with gift aid and are at 34% of our target. To those 90% of you listening who have not pledged, surely you can spare a tenner. You can donate £10 HERE. 

I previously looked at AIM-listed Haydale (HAYD) last October (HERE), concluding It may be a great business in the making, but the lack of visibility of earnings (just £6 million over the next 3.5 years) is too thin – profits seem an awfully long way away and the carefully crafted obfuscation in the trading statement makes me steer a wide berth…. Today we got a warning that sales have been disappointing, the CEO stepping aside and cash sitting at £5.6 million. Given that it raised £9.3 million last October (at a 32% discount) one has to wonder how long it will be before the tin is rattled again.

AIM-listed Haydale (HAYD) joined Applied Graphene (AGM) on the heavily discounted fundraising trail yesterday from the graphene sector of AIM (albeit it has other products as well). Not only has it announced its full year results to June, it offered the begging bowl at not less that 120p per share. Given that the stock closed last night at 176p, it suggests that the company was expecting a frosty reception. At the low point the stock was trading down 54.5p at 121.5p before a recovery to 125.5.

Some companies are so transparent. I look at the RNS from Savannah Resources (SAV), do the maths and predict a placing within weeks. I then crow about one I called earlier, Applied Graphene Materials (AGM). Then it is onto Interquest (ITQ) which is back on the AIM casino thanks to Nomad Allenby, a firm that I take to task for being morally bankrupt. I look at Johnston  Press (JPR) which is nothing to do with Luke Johnson who is also mentioned. I then look at Advanced Oncotherapy (AVO) and i3 Energy (i3E) as well as the dog Haydale (HAYD)